BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31261543)

  • 1. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study.
    Lee SW; Sung JK; Cho YS; Bang KB; Kang SH; Kim KB; Kim SH; Moon HS; Song KH; Kim SM; Chung IK; Lee DS; Jeong HY; Youn SJ
    Medicine (Baltimore); 2019 Jun; 98(26):e16154. PubMed ID: 31261543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Management of Diminutive Duodenal Neuroendocrine Tumors.
    Klemm N; Lu-Cleary D; Chahal D; Trasolini R; Lam E; Donnellan F
    J Gastrointest Cancer; 2021 Jun; 52(2):448-453. PubMed ID: 33471257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
    Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
    J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognostic factors of duodenal neuroendocrine tumours: A comparative study of ampullary and nonampullary regions.
    Fang S; Shi YP; Wang L; Han S; Shi YQ
    World J Gastrointest Oncol; 2024 Mar; 16(3):907-918. PubMed ID: 38577444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience.
    Matsumoto S; Yoshida Y
    World J Gastroenterol; 2014 Jul; 20(26):8624-30. PubMed ID: 25024618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
    J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results.
    Shamali A; McCrudden R; Bhandari P; Shek F; Barnett E; Bateman A; Abu Hilal M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1388-1393. PubMed ID: 27603299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors.
    Ragheb J; Mony S; Klapman J; Erim T; Reagan A; Butler R; Dong Y; Cruise M; Centeno BA; Bejarano P; Stevens T; Hayat U; Bhatt A
    Gastrointest Endosc; 2021 Sep; 94(3):580-588. PubMed ID: 33676923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic resection for duodenal subepithelial tumors: a single-center experience.
    Kim TW; Kim GH; Park DY; Ahn S; Lim W; Lee BE; Song GA
    Surg Endosc; 2017 Apr; 31(4):1936-1946. PubMed ID: 27553800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma.
    Seo JY; Hong SJ; Han JP; Jang HY; Myung YS; Kim C; Lee YN; Ko BM
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1692-8. PubMed ID: 24720570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
    Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
    BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors.
    Yi K; Kim GH; Kim SJ; Choi CW; Lee MW; Lee BE; Song GA
    Sci Rep; 2023 Oct; 13(1):17908. PubMed ID: 37863959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome of endoscopic resection for nonampullary duodenal tumors.
    Nonaka S; Oda I; Tada K; Mori G; Sato Y; Abe S; Suzuki H; Yoshinaga S; Nakajima T; Matsuda T; Taniguchi H; Saito Y; Maetani I
    Endoscopy; 2015 Feb; 47(2):129-35. PubMed ID: 25314330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
    Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
    Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Endoscopic Management is Reasonable for <2 cm Duodenal Neuroendocrine Tumors.
    Tran CG; Sherman SK; Howe JR
    Ann Surg Oncol; 2022 Jan; 29(1):85-86. PubMed ID: 34608558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.